Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Just 3 nights of shift work may weaken bones, small study suggests

NCT ID NCT05074277

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether working night shifts for just three nights in a row can disrupt bone health. Twenty healthy adults aged 20-40 either followed a normal sleep schedule or stayed awake at night and slept during the day. Researchers measured bone turnover markers to see if the body's bone-building and bone-breaking processes become unbalanced. The goal is to understand why shift workers face higher osteoporosis risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help explain why night shift workers have higher rates of osteoporosis, pointing toward future prevention strategies.
What could go wrong
This is a very small, early-stage study with only 20 participants. Results may not apply to real-world shift workers or lead to any direct health changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Feb 2022

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Healthy, nonpregnant adults 20-40 years old who habitually sleep 7-9 hours during the biological night o Women must be premenopausal, on continuous combination oral contraception and not breastfeeding. * Willing and able to complete a sleep diary, wear a wrist actigraphy monitor and complete a 3-6 week research study including two 4-night inpatient stays. * Fully vaccinated against SARS-CoV-2, and willing to produce a negative COVID test result before their first inpatient stay. Exclusion Criteria * Regularly go to sleep after midnight. * Night shift work within 1 year prior to study. * Travel \> 1 time zone within 4 weeks prior to the study or need to travel \>1 time zone during study. * Physical activity level/regimen incompatible with inpatient CTRC stay. * Current smokers (or within the previous year of study) * Positive drug test at screening or inpatient admission * BMI \> 30 kg/m2 * Individuals who are concurrently participating in another research protocol that would influence their safe participation in this study. For example, participants involved in a study that requires blood draws or ingestion of experimental medication as this would increase the risk of participation in our study and/or compromise study results. * Any clinically significant unstable medical or surgical condition within the last year (treated or untreated), including history of a clinically significant abnormality of the neurological system (including cognitive disorders or significant head injury) or any history of seizure (including febrile seizure-sleep loss has been used clinically to induce seizures in patients with epilepsy). Given the wide range of illnesses that are encountered in medical practice, it would not be possible to provide a comprehensive list of each and every disease that could serve as grounds for exclusion for the subject. However, the following is a list of illness categories that would certainly be grounds for exclusion: Connective Tissue and Joint Disorders; Neurologic/cognitive Disorders; Musculoskeletal Disorders; Immune Disorders; Chronobiologic Disorders; Cardiovascular Disorders; Respiratory Disorders; Kidney Disorders; Infectious Diseases; Hematopoietic Disorders; Neoplastic Diseases; and Endocrine and Metabolic Diseases. * Self-reported or newly diagnosed medical condition that is still being investigated or is not under good control, including those identified on screening labs such as: o Out-of-range values measured on a fasting blood sample: glucose \> 100 mg/dl, thyroid stimulating hormone \<0.5 or \>5.0 uU/ml, abnormal alkaline phosphatase \<39 or \>117 U/l, creatinine, or hemoglobin \<14.5 g/dl men * Any clinically significant psychiatric condition, as defined by DSM-V. Individuals with a history of most psychiatric illnesses or psychiatric disorders will be excluded, such as but not limited to depression, anxiety, alcoholism, drug dependency, schizophrenic disorders, and personality disorders (performed by medical history and physician interview). However, a personal history of limited prior counseling, psychotherapy (e.g., for adjustment reactions) will NOT be exclusionary. * Evaluation of Psychiatric/Psychological Suitability: * Inability to demonstrate a full understanding of the requirements and demands of the study. * Each participant will complete psychological screening questionnaires. Exclusionary: Center for Epidemiological Studies Depression (CES-D) \> 16. Subject responses to the CES-D are reviewed immediately and appropriate referrals are made if necessary. * Individuals who are unaware of specific psychiatric diagnoses who have a history of having been treated with antidepressants, neuroleptic medications or major tranquilizers will be excluded from study. * Use of anti-depressants or any like therapeutics prescribed by a physician is exclusionary * Individuals with any clinically significant sleep disorder; Diagnosis or symptoms of sleep disorders (history of significant parasomnia as an adult \[night terrors, frequent sleep walking\], insomnia, including but not limited to hypersomnias such as apnea, periodic limb movements, narcolepsy). Sleep disorders will be screened by self-report and physician interview including use of validated sleep questionnaires (PSQI, Epworth sleepiness scale, and Berlin sleep questionnaire for sleep apnea). The following scores will be used to exclude those with sleep disorders: PSQI \>5, Epworth Sleepiness Scale \>9. * Individuals on medications known to affect bone turnover (e.g., glucocorticoids, osteoporosis medications); * Use of medications/supplements/drugs that impact sleep or bone metabolism (such as but not limited to sleep medications, marijuana, etc.) within one month (participants can be studied at a later date). * Dwelling below Denver altitude (1,600 m) 1 month prior to enrollment. * Greater than moderate caffeine (\>500 mg/day) or alcohol use (\>14 standard drinks/ week or \>5 drinks in one sitting) * Inability to travel to the CU-AMC campus for study visits. * Individuals with restrictive diets (e.g., vegan) * Individuals with 25OHD \< 20 ng/mL (may be studied at a later date) * Individuals with eGFR \< 60 mL/min/1.73m2 as this is known to affect CTX measurements. * Z-score \< -2.0 for bone mineral density at the L-spine, femoral neck, or total hip on baseline DXA as compared to the DXA machine's normative database. * Symptoms of active illness (e.g., fever) at time of enrollment; note - participant may be studied at a later date. * Restrictive diets that cannot be accommodated by the CTRC Nutrition Core * Any other reason that participant may not be able to safely complete the entire study, at PI discretion

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Circadian rhythm sleep disorder, shift work type are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CU Anschutz

    Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.